SYNAPTIC PHARMACEUTICAL CORP
10-Q, EX-27, 2000-08-04
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SYNAPTIC PHARMACEUTICAL CORP, 10-Q, 2000-08-04
Next: DREYFUS CALIFORNIA INTERMEDIATE MUNICIPAL BOND FUND, 497J, 2000-08-04



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                       4,193,000
<SECURITIES>                                32,253,000
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            18,210,000
<PP&E>                                      11,951,000
<DEPRECIATION>                               6,717,000
<TOTAL-ASSETS>                               5,234,000
<CURRENT-LIABILITIES>                        2,659,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       108,000
<OTHER-SE>                                  39,790,000
<TOTAL-LIABILITY-AND-EQUITY>                42,968,000
<SALES>                                              0
<TOTAL-REVENUES>                               568,000
<CGS>                                                0
<TOTAL-COSTS>                                9,517,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (7,798,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (7,798,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (7,798,000)
<EPS-BASIC>                                     (0.72)
<EPS-DILUTED>                                   (0.72)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission